Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Iguratimod. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel three-step route for 5-methoxy-2-phenoxyaniline enhances safety and supply chain stability for global pharmaceutical intermediates manufacturing partners.
Patent CN117700340B reveals homogeneous catalytic route for Iguratimod intermediate. Enhances purity and yield for reliable pharmaceutical intermediate supply chains.
Novel patent CN116891450B offers safer Iguratimod synthesis. Reduces toxic reagents, enhances purity for reliable pharmaceutical intermediates supply chain stability.
Patent CN112209859B reveals a safer CDI-based route for Iguratimod intermediates, offering high purity and reduced operational hazards for API manufacturing.
Patent CN111087356B reveals a high-yield convergent synthesis for Iguratimod intermediates, offering significant cost reduction in API manufacturing and improved supply chain reliability.